J&J Beats Estimates and Boosts Outlook as Medtech Product Demand Grows
- Investing News
admin
- 0
- 1 minute read
Shares of Johnson & Johnson advanced as the pharmaceutical and medical products firm posted better-than-expected results and raised its guidance on higher demand for its medtech products.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1132711574-388eca9691b24bcea4b6ddac521bac25.jpg "Divorce Planning Checklist")
:max_bytes(150000):strip_icc():format(jpeg)/PaperworkatDesk-1a3837aec527439dbbf86d99a89611ba.jpg "2024 and 2025 Federal Income Tax Brackets, Standard Deductions, and Tax Rates")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1245836826-2b88234057c442f7bf5538ddb7f7584a.jpg "What It Would Take for the U.S. Dollar To Collapse")